The activation of PPARγ may be an effective therapeutic approach in COPD, as it reduced cigarette smoke-induced inflammation and decreased the magnitude of bacterial infection-caused exacerbations [99]. Here, PPARG is linked to chronic obstructive pulmonary disease.